Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

The Development of Nitric Oxide Donor Drugs as Targeted Anti-Cancer Therapeutics

A postgraduate research opportunity at the University of Otago.

Details

Close date
Saturday, 30 November 2019
Academic background
Sciences, Health Sciences
Host campus
Dunedin
Qualifications
PhD, Master’s
Department
Pharmacology and Toxicology
Supervisor
Dr Gregory Giles

Overview

Nitric oxide is a potent signalling molecule involved in the regulation of the cardiovascular system, neurotransmission, and the immune response. We are developing new nitric oxide releasing drugs to combat a range of diseases, with a focus on cancer therapy. Opportunities exist for students interested in synthetic approaches to drug discovery, drug formulation, and the analysis of drug mechanism-of-action, to join our multi-disciplinary team to help develop these new therapeutic agents towards clinical trials. Successful applicants will train in a drug discovery programme that provides a pathway into a career in the pharmaceutical sector, and candidates with a background in chemistry, biochemistry, or pharmacology, are strongly encouraged to apply.

Contact

Dr Gregory Giles
Tel   +64 3 479 7322
Email   gregory.giles@otago.ac.nz